HEADER TRANSFERASE 28-JUN-04 1TV6 TITLE HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE P66 SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.7.4; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: REVERSE TRANSCRIPTASE P51 SUBUNIT; COMPND 8 CHAIN: B; COMPND 9 EC: 2.7.7.4; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 3 ORGANISM_TAXID: 11678; SOURCE 4 GENE: POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PKRT; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 12 ORGANISM_TAXID: 11678; SOURCE 13 GENE: POL; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PKRT KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.D.PATA,W.G.STIRTAN,S.W.GOLDSTEIN,T.A.STEITZ REVDAT 3 23-AUG-23 1TV6 1 REMARK REVDAT 2 24-FEB-09 1TV6 1 VERSN REVDAT 1 20-JUL-04 1TV6 0 JRNL AUTH J.D.PATA,W.G.STIRTAN,S.W.GOLDSTEIN,T.A.STEITZ JRNL TITL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO AN JRNL TITL 2 INHIBITOR ACTIVE AGAINST MUTANT RTS RESISTANT TO OTHER JRNL TITL 3 NON-NUCLEOSIDE INHIBITORS JRNL REF PROC.NATL.ACAD.SCI.USA V. 101 10548 2004 JRNL REFN ISSN 0027-8424 JRNL PMID 15249669 JRNL DOI 10.1073/PNAS.0404151101 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.J.SMERDON,J.JAEGER,J.WANG,L.A.KOHLSTAEDT,A.J.CHIRINO, REMARK 1 AUTH 2 J.M.FRIEDMAN,P.A.RICE,T.A.STEITZ REMARK 1 TITL STRUCTURE OF THE BINDING SITE FOR NONNUCLEOSIDE INHIBITORS REMARK 1 TITL 2 OF THE REVERSE TRANSCRIPTASE OF HUMAN IMMUNODEFICIENCY VIRUS REMARK 1 TITL 3 TYPE 1 REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 91 3911 1994 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 2 REMARK 1 AUTH L.A.KOHLSTAEDT,J.WANG,J.M.FRIEDMAN,P.A.RICE,T.A.STEITZ REMARK 1 TITL CRYSTAL STRUCTURE AT 3.5 A RESOLUTION OF HIV-1 REVERSE REMARK 1 TITL 2 TRANSCRIPTASE COMPLEXED WITH AN INHIBITOR REMARK 1 REF SCIENCE V. 256 1783 1992 REMARK 1 REFN ISSN 0036-8075 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2279111.090 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.4 REMARK 3 NUMBER OF REFLECTIONS : 35855 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.262 REMARK 3 FREE R VALUE : 0.312 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1995 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5020 REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7759 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.79000 REMARK 3 B22 (A**2) : -8.29000 REMARK 3 B33 (A**2) : -4.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 20.51000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM SIGMAA (A) : 0.60 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.53 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.64 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.096 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.840 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.310 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.320 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.570 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 33.31 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THIS STRUCTURE WAS REFINED AGAINST DATA REMARK 3 THAT WERE SHARPENED BY APPLYING A B-FACTOR CORRECTION OF -60 REMARK 3 USING THE CCP4 PROGRAM CAD. THESE SHARPENED DATA ARE CONTAINED REMARK 3 IN THE STRUCTURE FACTOR FILE FOR THIS ENTRY. REMARK 4 REMARK 4 1TV6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-04. REMARK 100 THE DEPOSITION ID IS D_1000022931. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37716 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 29.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 3HVT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM BIS-TRIS-PROPANE, 100 MM REMARK 280 AMMONIUM SULFATE, 0.2% (W/V) BETA-OCTYLGLUCOSIDE, 10% (V/V) REMARK 280 GLYCEROL, 14% (W/V) PEG-8000, PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 111.95500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.52000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 111.95500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.52000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 219 REMARK 465 LYS A 220 REMARK 465 HIS A 221 REMARK 465 GLN A 222 REMARK 465 LYS A 540 REMARK 465 GLY A 541 REMARK 465 ILE A 542 REMARK 465 GLY A 543 REMARK 465 GLY A 544 REMARK 465 ASN A 545 REMARK 465 GLU A 546 REMARK 465 GLN A 547 REMARK 465 VAL A 548 REMARK 465 ASP A 549 REMARK 465 LYS A 550 REMARK 465 LEU A 551 REMARK 465 VAL A 552 REMARK 465 SER A 553 REMARK 465 ALA A 554 REMARK 465 GLY A 555 REMARK 465 ILE A 556 REMARK 465 ARG A 557 REMARK 465 LYS A 558 REMARK 465 ILE A 559 REMARK 465 LEU A 560 REMARK 465 PRO B 1 REMARK 465 ILE B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 ILE B 5 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 LEU B 429 REMARK 465 GLU B 430 REMARK 465 LYS B 431 REMARK 465 GLU B 432 REMARK 465 PRO B 433 REMARK 465 ILE B 434 REMARK 465 VAL B 435 REMARK 465 GLY B 436 REMARK 465 ALA B 437 REMARK 465 GLU B 438 REMARK 465 THR B 439 REMARK 465 PHE B 440 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY B 213 N THR B 215 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 14 C - N - CA ANGL. DEV. = 10.3 DEGREES REMARK 500 LYS A 424 N - CA - C ANGL. DEV. = 17.3 DEGREES REMARK 500 ARG B 358 N - CA - C ANGL. DEV. = 16.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 14 -64.17 -13.22 REMARK 500 MET A 16 -168.47 -105.99 REMARK 500 VAL A 21 120.71 -35.35 REMARK 500 LEU A 26 -156.31 -147.83 REMARK 500 THR A 27 128.10 -36.89 REMARK 500 ILE A 31 -6.73 -53.14 REMARK 500 PRO A 55 11.57 -55.68 REMARK 500 THR A 69 -24.02 103.50 REMARK 500 ARG A 78 -29.18 -38.54 REMARK 500 GLN A 85 174.18 -47.72 REMARK 500 GLU A 89 130.59 -30.51 REMARK 500 VAL A 90 91.34 -60.96 REMARK 500 GLN A 91 101.26 -24.78 REMARK 500 ASP A 113 41.92 -68.24 REMARK 500 GLU A 122 -73.72 -44.22 REMARK 500 ASP A 123 -14.89 -48.89 REMARK 500 TYR A 127 -5.37 -53.51 REMARK 500 PRO A 133 -129.50 -50.34 REMARK 500 SER A 134 -172.81 -170.63 REMARK 500 ASN A 137 74.65 -23.97 REMARK 500 GLU A 138 -38.57 -156.72 REMARK 500 ILE A 142 81.79 -69.64 REMARK 500 TYR A 144 -168.31 -117.46 REMARK 500 MET A 184 -63.11 61.35 REMARK 500 ASP A 185 13.97 -163.14 REMARK 500 LEU A 193 -143.69 -74.40 REMARK 500 ILE A 195 -33.70 -32.95 REMARK 500 PRO A 225 -42.84 -15.28 REMARK 500 TRP A 229 124.95 -30.64 REMARK 500 MET A 230 79.86 -0.72 REMARK 500 PRO A 236 -5.47 -58.04 REMARK 500 ASP A 237 17.88 -174.20 REMARK 500 GLN A 269 10.88 -60.45 REMARK 500 ILE A 270 -27.80 -160.73 REMARK 500 VAL A 276 -2.14 -152.21 REMARK 500 LEU A 289 156.06 -39.84 REMARK 500 LEU A 295 -152.67 -69.14 REMARK 500 LYS A 311 -76.46 -35.51 REMARK 500 PRO A 321 2.78 -51.97 REMARK 500 GLN A 332 -112.34 -99.05 REMARK 500 PHE A 346 79.66 19.77 REMARK 500 LYS A 347 81.87 174.16 REMARK 500 MET A 357 -71.02 -46.76 REMARK 500 ALA A 360 87.14 -41.34 REMARK 500 HIS A 361 83.78 38.59 REMARK 500 PRO A 392 46.17 -69.04 REMARK 500 TRP A 410 108.21 -177.25 REMARK 500 PRO A 412 -164.96 -58.23 REMARK 500 ASN A 418 87.22 -54.16 REMARK 500 LEU A 425 45.98 -146.43 REMARK 500 REMARK 500 THIS ENTRY HAS 106 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE REFERENCE FOR THE BOUND INHIBITOR (CP-94,707): REMARK 600 GOLDSTEIN, S.W., STIRTAN, W.G. & SHERER, B.A. (2001) REMARK 600 US PATENT 6,242,461 (PFIZER, INC.), CAN 135:19641. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CP9 A 561 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HVT RELATED DB: PDB REMARK 900 THE SAME CRYSTAL FORM WITH HIV-1 REVERSE TRANSCRIPTASE COMPLEXED REMARK 900 WITH NEVIRAPINE. DBREF 1TV6 A 1 560 UNP P03366 POL_HV1B1 168 727 DBREF 1TV6 B 1 440 UNP P03366 POL_HV1B1 168 607 SEQRES 1 A 560 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 560 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 560 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 560 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 560 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 560 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 560 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 560 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 560 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 560 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 560 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 560 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 560 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 560 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 560 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 560 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 560 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 560 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 560 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 560 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 560 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 560 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 A 560 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 560 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 560 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 560 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 560 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 560 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 560 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 560 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 560 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 560 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 560 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 560 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 560 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 560 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 560 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 560 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 560 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 560 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 560 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 560 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 560 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS ILE SEQRES 44 A 560 LEU SEQRES 1 B 440 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 440 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 440 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 440 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 440 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 440 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 440 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 440 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 440 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 440 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 440 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 440 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 440 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 440 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 440 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 440 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 440 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 440 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 440 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 440 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 440 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 440 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 B 440 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 440 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 440 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 440 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 440 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 440 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 440 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 440 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 440 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 440 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 440 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 B 440 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE HET CP9 A 561 27 HETNAM CP9 3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H- HETNAM 2 CP9 BENZOTHIAZOL-2-ONE HETSYN CP9 CP-94,707 FORMUL 3 CP9 C21 H16 N4 O S HELIX 1 1 GLU A 29 GLU A 44 1 16 HELIX 2 2 PHE A 77 LYS A 82 1 6 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 GLY A 112 VAL A 118 5 7 HELIX 5 5 ASP A 121 ALA A 129 5 9 HELIX 6 6 GLY A 155 ASN A 175 1 21 HELIX 7 7 GLY A 196 ARG A 211 1 16 HELIX 8 8 LEU A 228 MET A 230 5 3 HELIX 9 9 THR A 253 GLN A 269 1 17 HELIX 10 10 VAL A 276 LEU A 282 1 7 HELIX 11 11 LEU A 283 GLY A 285 5 3 HELIX 12 12 THR A 296 LYS A 311 1 16 HELIX 13 13 ASN A 363 GLY A 384 1 22 HELIX 14 14 GLN A 394 TYR A 405 1 12 HELIX 15 15 THR A 473 ASP A 488 1 16 HELIX 16 16 SER A 499 ALA A 508 1 10 HELIX 17 17 SER A 515 LYS A 528 1 14 HELIX 18 18 THR B 27 GLU B 44 1 18 HELIX 19 19 PHE B 77 ARG B 83 1 7 HELIX 20 20 THR B 84 VAL B 90 1 7 HELIX 21 21 GLY B 112 TYR B 115 5 4 HELIX 22 22 PHE B 124 ALA B 129 5 6 HELIX 23 23 SER B 134 GLU B 138 5 5 HELIX 24 24 LYS B 154 LYS B 173 1 20 HELIX 25 25 GLU B 194 TRP B 212 1 19 HELIX 26 26 HIS B 235 TRP B 239 5 5 HELIX 27 27 THR B 253 SER B 268 1 16 HELIX 28 28 LEU B 279 LEU B 283 5 5 HELIX 29 29 THR B 296 LEU B 310 1 15 HELIX 30 30 ASN B 363 GLY B 384 1 22 HELIX 31 31 GLN B 394 TRP B 402 1 9 HELIX 32 32 THR B 403 TYR B 405 5 3 HELIX 33 33 LEU B 422 TYR B 427 1 6 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ARG A 143 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 A 3 PHE A 130 THR A 131 -1 N PHE A 130 O TYR A 144 SHEET 1 B 2 VAL A 60 LYS A 64 0 SHEET 2 B 2 TRP A 71 VAL A 75 -1 O ARG A 72 N ILE A 63 SHEET 1 C 3 SER A 105 ASP A 110 0 SHEET 2 C 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 C 3 VAL A 179 TYR A 183 -1 O TYR A 183 N ASP A 186 SHEET 1 D 2 TYR A 232 LEU A 234 0 SHEET 2 D 2 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 1 E 5 LYS A 350 ALA A 355 0 SHEET 2 E 5 GLN A 336 TYR A 342 -1 N ILE A 341 O LYS A 350 SHEET 3 E 5 ILE A 326 LYS A 331 -1 N GLN A 330 O THR A 338 SHEET 4 E 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 E 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 F 5 GLN A 464 THR A 470 0 SHEET 2 F 5 LEU A 452 THR A 459 -1 N ALA A 455 O VAL A 467 SHEET 3 F 5 THR A 439 ALA A 446 -1 N ALA A 445 O LYS A 454 SHEET 4 F 5 GLU A 492 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 F 5 LYS A 530 TRP A 535 1 O TYR A 532 N ILE A 495 SHEET 1 G 3 ILE B 47 LYS B 49 0 SHEET 2 G 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 G 3 PHE B 130 ILE B 132 -1 N PHE B 130 O TYR B 144 SHEET 1 H 2 VAL B 60 LYS B 64 0 SHEET 2 H 2 TRP B 71 VAL B 75 -1 O ARG B 72 N ILE B 63 SHEET 1 I 4 VAL B 179 TYR B 183 0 SHEET 2 I 4 ASP B 186 SER B 191 -1 O TYR B 188 N TYR B 181 SHEET 3 I 4 SER B 105 ASP B 110 -1 N LEU B 109 O LEU B 187 SHEET 4 I 4 GLU B 233 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 J 5 LYS B 350 GLY B 352 0 SHEET 2 J 5 GLN B 336 TYR B 342 -1 N ILE B 341 O LYS B 350 SHEET 3 J 5 ILE B 326 GLY B 333 -1 N GLN B 330 O THR B 338 SHEET 4 J 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 J 5 GLU B 413 PHE B 416 1 O GLU B 415 N LEU B 391 CISPEP 1 PRO A 420 PRO A 421 0 0.02 SITE 1 AC1 10 PRO A 95 LEU A 100 VAL A 106 VAL A 108 SITE 2 AC1 10 TYR A 181 TYR A 188 LEU A 234 HIS A 235 SITE 3 AC1 10 PRO A 236 TYR A 318 CRYST1 223.910 69.040 104.330 90.00 106.64 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004466 0.000000 0.001335 0.00000 SCALE2 0.000000 0.014485 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010004 0.00000